Cover Image
市場調查報告書

數位PCR (dPCR) 及即時PCR (qPCR)的全球市場預測 2022年:癌症、血液檢驗、病原體檢測、研究、司法鑑定

Digital PCR & Real-time PCR (qPCR) Market by Technology (qPCR, dPCR), Product (Instrument, Reagent), Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, CRO) - Forecast to 2022

出版商 MarketsandMarkets 商品編碼 324624
出版日期 內容資訊 英文 218 Pages
訂單完成後即時交付
價格
Back to Top
數位PCR (dPCR) 及即時PCR (qPCR)的全球市場預測 2022年:癌症、血液檢驗、病原體檢測、研究、司法鑑定 Digital PCR & Real-time PCR (qPCR) Market by Technology (qPCR, dPCR), Product (Instrument, Reagent), Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, CRO) - Forecast to 2022
出版日期: 2017年06月27日 內容資訊: 英文 218 Pages
簡介

全球數位PCR (dPCR) 及即時PCR (qPCR) 市場規模,預計從2017年到2022年以8.9%的年複合成長率發展,到2022年達到53億1,000萬美元。促進該市場的成長的主要原因,為老年人口的增加,感染疾病、遺傳性疾病的發病率的上升,以PCR為基礎的研究的投資、資金有效性的擴大,及疾病診斷上生物標記分析的利用擴大等。可是,dPCR產品高額,及dPCR、qPCR相關技術性限制,抑制該市場的成長。

本報告提供全球數位PCR (dPCR) 及定量PCR (qPCR) 市場相關調查分析,各技術、產品和服務、用途、終端用戶,及地區的市場分析與預測,競爭情形分析,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • dPCR、qPCR市場概要
  • 全球qPCR、dPCR技術市場:各地區
  • 全球qPCR、dPCR的市場佔有率:各產品及服務
  • 地區分析:qPCR市場,各應用領域
  • 地區分析:dPCR,各應用領域

第5章 市場概要

  • 簡介
  • qPCR、dPCR的技術發展
  • 市場動態
    • 主要的市場成長的促進要素
    • 主要市場成長的阻礙因素
    • 主要市場機會
    • 主要市場課題

第6章 產業趨勢

  • 簡介
  • 價值鏈分析
  • 產業趨勢
    • 實驗室晶片PCR設備的開發
    • 現行技術和PCR流程的整合
  • 波特的五力分析

第7章 全球qPCR、dPCR市場:各技術

  • 簡介
  • 定量PCR (qPCR)
  • 數位PCR (dPCR)

第8章 全球qPCR、dPCR市場:各產品及服務

  • 簡介
  • qPCR產品及服務
    • 試劑、消耗品
    • 器具
    • 軟體及服務
  • dPCR產品及服務
    • 器具
    • 試劑、消耗品
    • 軟體及服務

第9章 qPCR、dPCR市場:各用途

  • 簡介
  • qPCR
    • 臨床
      • 病原體檢驗
      • 癌症檢驗
      • 血液篩檢
      • 其他臨床用途
    • 研究
    • 司法鑑定
  • dPCR
    • 臨床
    • 研究
    • 司法鑑定

第10章 qPCR、dPCR市場:各終端用戶

  • 簡介
  • qPCR
    • 醫院、診斷中心
    • 研究所、學術機構
    • 醫藥品、生物科技企業
    • 臨床研究機關
    • 司法鑑定機關
  • dPCR
    • 研究所、學術機構
    • 醫院、診斷中心
    • 醫藥品、生物科技企業
    • 臨床研究機關
    • 司法鑑定機關

第11章 qPCR、dPCR市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第12章 競爭情形

  • 概要
  • 供應商編入標準
  • 競爭龍頭製圖
  • 競爭基準
  • 市場佔有率分析

第13章 企業簡介

  • 簡介
  • F. HOFFMAN-LA ROCHE LTD.
  • THERMO FISHER SCIENTIFIC, INC.
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN N.V.
  • TaKaRa BIO
  • AGILENT TECHNOLOGIES, INC.
  • BIOMERIEUX S.A.
  • FLUIDIGM CORPORATION
  • DANAHER CORPORATION
  • ABBOTT LABORATORIES
  • MERCK KGAA
  • BECTON DICKINSON AND COMPANY
  • PROMEGA CORPORATION
  • MERIDIAN BIOSCIENCE, INC. (BIOLINE REAGENTS LTD.)
  • ANALYTIK JENA AG (ENDRESS+HAUSER AG)

第14章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 3161

"The global digital PCR and real-time (qPCR) market projected to grow at a CAGR of 8.9%."

The global dPCR and qPCR market is estimated to grow at a CAGR of 8.9% from 2017 to 2022, to reach USD 5.31 billion by 2022. The key factors driving the growth of this market include growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, increasing investments and availability of funds for PCR-based research, and increasing use of biomarker profiling for disease diagnosis. However, factors such as high cost of dPCR products and technical limitations associated with qPCR and dPCR are restraining the growth of this market.

"The dPCR technology segment to grow at faster pace than qPCR technology segment during the forecast period."

Based on the type of technology, the dPCR and qPCR market is classified into digital PCR (dPCR) and quantitative PCR (qPCR). In 2017, the qPCR technology segment is expected to account for the largest share of the market. However, the dPCR technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the ongoing technological developments in dPCR, significant adoption of dPCR products among target end users, expansion of distribution networks of emerging dPCR product manufacturers, and growing private funding for the development and commercialization of innovative dPCR instruments.

"The dPCR instruments segment is expected to grow at the highest CAGR during 2017-2022."

On the basis of product and service, the dPCR and qPCR market is categorized into instruments; reagents and consumables; and software and services. The dPCR instruments segment is expected to witness the highest growth during the forecast period. The growth of this segment is mainly due to the procedural benefits of dPCR over qPCR, growing market demand for dPCR procedures (particularly in forensics and drug discovery), and rising number of dPCR-based researches across the globe.

"Asia-Pacific to witness the highest growth during the forecast period (2017-2022)"

North America is expected to hold the largest share of the global dPCR and qPCR market in 2017, followed by Europe. However, the Asia-Pacific region is expected to grow at the fastest rate during the forecast period. Growing awareness of physicians & healthcare professionals about the benefits of gene-based disease diagnosis and treatment, growing public-private support to develop novel dPCR and qPCR technologies, strong growth witnessed by the Indian genomics industry, and advancing cancer research in Japan are the key factors responsible for the growth of this market in the Asia-Pacific region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-45%, Tier 2-34% and Tier 3-21%
  • By Designation - Director Level-14%, C-level-10%, Others-76%
  • By Region - North America-40%, Europe-32%, Asia-Pacific-20%, RoW-8%

Some of the major market players in the dPCR and qPCR market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (U.S.), Agilent Technologies Inc. (U.S.), bioMerieux S.A. (France), Fluidigm Corporation (U.S.), Danaher Corporation (U.S.), and Abbott Laboratories (U.S.), among others.

Research Coverage:

This report studies the dPCR and qPCR market based on technology, product and service, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report forecasts the revenue of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The dPCR and qPCR market report profiles key players who are involved in the manufacturing and commercialization of dPCR and qPCR products and analyzes their core competencies. The report tracks and analyzes competitive developments such as new product launches and enhancements; mergers and acquisition; partnerships, collaborations and agreements; and expansions in the dPCR and qPCR market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the dPCR and qPCR market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the top 10 players in the dPCR and qPCR market. The report analyzes the Digital PCR (dPCR) and qPCR market by technology, product and service, application, end user, and region
  • Product Development/Innovation: Detailed insights on research and development activities, developmental pipeline, and new product launches in the dPCR and qPCR market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various dPCR and qPCR products across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World)
  • Competitive Assessment: Assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the dPCR and qPCR market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. FACTOR ANALYSIS
    • 2.2.1. INTRODUCTION
    • 2.2.2. DEMAND-SIDE ANALYSIS
      • 2.2.2.1. Healthcare expenditure patterns
      • 2.2.2.2. Rapid growth of aging population
      • 2.2.2.3. Incidence and prevalence of cancer
      • 2.2.2.4. Birth rate/pregnancies
      • 2.2.2.5. Burden of infectious diseases
      • 2.2.2.6. Number of clinical, forensics, and research laboratories
    • 2.2.3. SUPPLY-SIDE ANALYSIS
      • 2.2.3.1. Number of product launches: qPCR and dPCR vs. Competitive technologies
      • 2.2.3.2. Parent market analysis: polymerase chain reaction (PCR) market
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. TOP-DOWN APPROACH
    • 2.3.2. BOTTOM-UP APPROACH
      • 2.3.2.1. Bottom-up approach: dPCR and qPCR instruments and software
      • 2.3.2.2. Bottom-up approach: dPCR and qPCR reagents
  • 2.4. DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. DPCR AND QPCR MARKET OVERVIEW (2017-2022)
  • 4.2. GLOBAL QPCR AND DPCR TECHNOLOGY MARKET, BY REGION 2017 VS.2022 (USD MILLION)
  • 4.3. GLOBAL QPCR AND DPCR MARKET SHARE, BY PRODUCT AND SERVICE (2017)
  • 4.4. REGIONAL ANALYISS: QPCR MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • 4.5. REGIONAL ANALYSIS: DPCR MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. TECHNOLOGICAL EVOLUTION IN QPCR/DPCR
  • 5.3. MARKET DYNAMICS
    • 5.3.1. MAJOR MARKET DRIVERS
      • 5.3.1.1. Rising incidences of infectious diseases and genetic disorders
      • 5.3.1.2. Technological advancement in PCR technologies
      • 5.3.1.3. Increasing public-private investments, funds, and grants
      • 5.3.1.4. Increasing use of biomarker profiling for disease diagnostics
      • 5.3.1.5. Successful completion of the human genome project
    • 5.3.2. MAJOR MARKET RESTRAINTS
      • 5.3.2.1. High device costs associated with dPCR
      • 5.3.2.2. Technical limitations of qPCR and dPCR techniques
    • 5.3.3. MAJOR MARKET OPPORTUNITIES
      • 5.3.3.1. Growing market penetration in emerging countries
      • 5.3.3.2. Shift from plant-derived to genome-based drug discovery
    • 5.3.4. MAJOR MARKET CHALLENGES
      • 5.3.4.1. Adoption and implementation of MIQE guidelines for publishing qPCR and dPCR-based research

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. INDUSTRY TRENDS
    • 6.3.1. DEVELOPMENT OF LAB-ON-CHIP PCR DEVICES
    • 6.3.2. ONGOING TECHNOLOGICAL INTEGRATION WITH PCR PROCESS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. QPCR MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 6.4.2. DPCR MARKET: PORTER'S FIVE FORCES ANALYSIS

7. GLOBAL qPCR AND dPCR MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. QUANTITATIVE PCR (QPCR)
  • 7.3. DIGITAL PCR (DPCR)

8. GLOBAL qPCR AND dPCR MARKET, BY PRODUCT AND SERVICE

  • 8.1. INTRODUCTION
  • 8.2. QPCR PRODUCTS AND SERVICES
    • 8.2.1. QPCR REAGENTS AND CONSUMABLES
    • 8.2.2. QPCR INSTRUMENTS
    • 8.2.3. QPCR SOFTWARE AND SERVICES
  • 8.3. DPCR PRODUCTS AND SERVICES
    • 8.3.1. DPCR INSTRUMENTS
    • 8.3.2. DPCR REAGENTS AND CONSUMABLES
    • 8.3.3. DPCR SOFTWARE AND SERVICES

9. qPCR AND dPCR MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. QPCR APPLICATIONS
    • 9.2.1. CLINICAL APPLICATIONS
      • 9.2.1.1. Pathogen testing
      • 9.2.1.2. Oncology testing
      • 9.2.1.3. Blood screening
      • 9.2.1.4. Other clinical applications
    • 9.2.2. RESEARCH APPLICATIONS
    • 9.2.3. FORENSIC APPLICATIONS
  • 9.3. DPCR APPLICATIONS
    • 9.3.1. CLINICAL APPLICATIONS
      • 9.3.1.1. Pathogen testing
      • 9.3.1.2. Oncology testing
      • 9.3.1.3. Blood screening
      • 9.3.1.4. Other clinical applications
    • 9.3.2. RESEARCH APPLICATIONS
    • 9.3.3. FORENSIC APPLICATIONS

10. qPCR AND dPCR MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. QUANTITATIVE PCR (QPCR) END USERS
    • 10.2.1. HOSPITALS AND DIAGNOSTIC CENTERS
    • 10.2.2. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
    • 10.2.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 10.2.4. CLINICAL RESEARCH ORGANIZATIONS
    • 10.2.5. FORENSIC LABORATORIES
  • 10.3. DIGITAL PCR (DPCR) END USERS
    • 10.3.1. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
    • 10.3.2. HOSPITALS AND DIAGNOSTIC CENTERS
    • 10.3.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 10.3.4. CLINICAL RESEARCH ORGANIZATIONS
    • 10.3.5. FORENSIC LABORATORIES

11. qPCR AND dPCR MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. U.K.
    • 11.3.3. FRANCE
    • 11.3.4. REST OF EUROPE
  • 11.4. ASIA-PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF APAC (ROAPAC)
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. VENDOR INCLUSION CRITERIA
  • 12.3. COMPETITIVE LEADERSHIP MAPPING
    • 12.3.1. VISIONARY LEADERS
    • 12.3.2. INNOVATORS
    • 12.3.3. DYNAMIC DIFFERENTIATORS
    • 12.3.4. EMERGING COMPANIES
  • 12.4. COMPETITVE BENCHMARKING
    • 12.4.1. ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE DPCR AND QPCR MARKET (25 PLAYERS)
    • 12.4.2. BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE DPCR AND QPCR MARKET (25 PLAYERS)
  • 12.5. MARKET SHARE ANALYSIS
    • 12.5.1. QPCR MARKET SHARE ANALYSIS (2016)
    • 12.5.2. DPCR MARKET SHARE ANALYSIS (2016)

Top 13 companies analysed for this study are - Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (U.S.), bioMerieux S.A. (France), Fluidigm Corporation (U.S.), Danaher Corporation (U.S.), Abbott Laboratories (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.), Becton, Dickinson and Company (U.S.), Meridian Bioscience, Inc. (U.S.), Analytik Jena AG (Germany), Eppendorf AG (Germany), Bioneer Corporation (South Korea), Enzo Life Science, Inc. (U.S.), Quanta Biosciences Inc. (U.S.), ELITech Group (France), Formulatrix, Inc. (U.S.), JN Medsys (Singapore), Denville Scientific Inc. (U.S.), Biomeme Inc. (U.S.), and Biosystemika, Research and Development LLC (Slovenia),

13. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 13.1. INTRODUCTION
  • 13.2. F. HOFFMAN-LA ROCHE LTD.
  • 13.3. THERMO FISHER SCIENTIFIC, INC.
  • 13.4. BIO-RAD LABORATORIES, INC.
  • 13.5. QIAGEN N.V.
  • 13.6. TAKARA BIO, INC.
  • 13.7. AGILENT TECHNOLOGIES, INC.
  • 13.8. BIOMERIEUX S.A.
  • 13.9. FLUIDIGM CORPORATION
  • 13.10. DANAHER CORPORATION
  • 13.11. ABBOTT LABORATORIES
  • 13.12. MERCK KGAA
  • 13.13. BECTON DICKINSON AND COMPANY
  • 13.14. PROMEGA CORPORATION
  • 13.15. MERIDIAN BIOSCIENCE, INC. (BIOLINE REAGENTS LTD.)
  • 13.16. ANALYTIK JENA AG (ENDRESS+HAUSER AG)

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14. APPENDIX

  • 14.1. INSIGHTS OF INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS
  • 14.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL QPCR AND DPCR MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 2: QPCR TECHNOLOGY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 3: DPCR TECHNOLOGY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: GLOBAL QPCR PRODUCTS AND SERVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: QPCR REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: QPCR INSTRUMENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: QPCR SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: GLOBAL DPCR PRODUCTS AND SERVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 9: DPCR INSTRUMENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: DPCR REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: DPCR SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: GLOBAL QPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 13: QPCR CLINICAL APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 14: QPCR CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: QPCR CLINICAL APPLICATION MARKET SIZE FOR PATHOGEN TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: QPCR CLINICAL APPLICATION MARKET SIZE FOR ONCOLOGY TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: QPCR CLINICAL APPLICATION MARKET SIZE FOR BLOOD SCREENING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: QPCR OTHER CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: QPCR RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: QPCR FORENSIC APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL DPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 22: DPCR CLINICAL APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 23: DPCR CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: DPCR CLINICAL APPLICATION MARKET SIZE FOR PATHOGEN TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: DPCR CLINICAL APPLICATION MARKET SIZE FOR ONCOLOGY TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: DPCR CLINICAL APPLICATION MARKET SIZE FOR BLOOD SCREENING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: DPCR OTHER CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: DPCR RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: DPCR FORENSIC APPLICATIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: GLOBAL QPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 31: QPCR MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: QPCR MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: QPCR MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: QPCR MARKET SIZE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: QPCR MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: GLOBAL DPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 37: DPCR MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: DPCR MARKET SIZE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: DPCR MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: DPCR MARKET SIZE FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: DPCR MARKET SIZE FOR FORENSIC LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 42: QPCR AND DPCR MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: DPCR AND QPCR MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: QPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: DPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: QPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: DPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 50: U.S.: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 51: U.S.: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 52: CANADA: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 53: CANADA: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 54: EUROPE: DPCR AND QPCR MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 56: EUROPE: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: QPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: DPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 59: EUROPE: QPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: EUROPE: DPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: GERMANY: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 62: GERMANY: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 63: U.K.: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 64: U.K.: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 65: FRANCE: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 66: FRANCE: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 67: ROE: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 68: ROE: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 69: APAC: DPCR AND QPCR MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 70: ASIA-PACIFIC: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 71: ASIA-PACIFIC: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 72: ASIA-PACIFIC: QPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: ASIA-PACIFIC: DPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: QPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 75: ASIA-PACIFIC: DPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 76: JAPAN: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 77: JAPAN: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 78: CHINA: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 79: CHINA: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 80: INDIA: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 81: INDIA: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 82: ROAPAC: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 83: ROAPAC: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 84: ROW: QPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 85: ROW: DPCR MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 86: ROW: QPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 87: ROW: DPCR MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 88: ROW: QPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 89: ROW: DPCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2000-2014
  • FIGURE 3: HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS: 2000-2014
  • FIGURE 4: INCREASE IN AGING POPULATION, BY COUNTRY (2011-2030)
  • FIGURE 5: PERCENTAGE INCREASE IN AGING POPULATION, BY REGION (1980-2010 VS. 2010-2040)
  • FIGURE 6: GLOBAL BURDEN OF CANCER, BY REGION (2005-2030)
  • FIGURE 7: NUMBER OF NEW CANCER CASES, BY COUNTRY (2012 VS. 2020)
  • FIGURE 8: INCREASING INCIDENCE OF VARIOUS CANCERS, 2008-2020
  • FIGURE 9: ANNUAL BIRTH RATE ACROSS DEVELOPED AND DEVELOPING NATIONS (2016)
  • FIGURE 10: GLOBAL PREVALENCE OF HIV INFECTIONS AMONG ADULTS (2015)
  • FIGURE 11: NUMBER OF PRODUCT LAUNCHES: QPCR AND DPCR VS. COMPETITIVE MODALITIES, 2013-2016
  • FIGURE 12: DPCR IS EXPECTED TO BE THE FASTEST-GROWING PCR TECHOLOGY TILL 2022
  • FIGURE 13: TOP-DOWN APPROACH
  • FIGURE 14: DATA TRIANGULATION
  • FIGURE 15: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 16: GLOBAL DPCR AND QPCR MARKET, BY TECHNOLOGY, 2017 VS. 2022
  • FIGURE 17: GLOBAL QPCR PRODUCT AND SERVICES MARKET, 2017 VS. 2022
  • FIGURE 18: GLOBAL DPCR PRODUCT AND SERVICES MARKET, 2017 VS. 2022
  • FIGURE 19: GLOBAL QPCR APPLICATIONS MARKET, 2017 VS. 2022
  • FIGURE 20: GLOBAL DPCR APPLICATIONS MARKET, 2017 VS. 2022
  • FIGURE 21: DPCR AND QPCR MARKET SHARE, BY REGION, 2017
  • FIGURE 22: MARKET GROWTH OPPORTUNITIES IN THE DPCR AND QPCR INDUSTRY
  • FIGURE 23: NORTH AMERICA EXPECTED TO DOMINATE QPCR AND DPCR MARKETS
  • FIGURE 24: REAGENTS AND CONSUMABLES TO DOMINATE THE QPCR AND DPCR PRODUCTS AND SERVICES MARKETS IN 2017
  • FIGURE 25: CLINICAL APPLICATION TO COMMAND THE LARGEST SHARE OF QPCR MARKET ACROSS ALL REGIONS IN 2017
  • FIGURE 26: CLINICAL APPLICATION TO COMMAND THE LARGEST SHARE OF DPCR MARKET ACROSS ALL REGIONS IN 2017
  • FIGURE 27: KEY EVOLUTIONARY MILESTONES IN THE FIELD OF QPCR AND DPCR
  • FIGURE 28: INCREASING PREVALENCE OF INFECTIOUS DISEASES AND GENETIC DISORDERS TO DRIVE THE MARKET DEMAND FOR DPCR AND QPCR PRODUCTS
  • FIGURE 29: GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2015
  • FIGURE 30: GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES (2015 VS. 2030)
  • FIGURE 31: TRADITIONAL PCR VS. QPCR AND DPCR: A COMPARATIVE STUDY
  • FIGURE 32: PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE-DEVELOPED VS. DEVELOPING COUNTRIES (2010-2014)
  • FIGURE 33: VALUE CHAIN ANALYSIS (2012-2017): MAJORITY OF VALUE IS ADDED TO OVERALL PRODUCT PRICE DURING MANUFACTURING PHASE
  • FIGURE 34: BUNDLED SALES STRATEGY ADOPTED BY KEY PRODUCT MANUFACTURERS IS LIMITING THREAT FROM NEW ENTRANTS
  • FIGURE 35: GROWING NUMBER OF NEW ENTRANTS IS AUGMENTING THE GROWING MARKET COMPETITION
  • FIGURE 36: DPCR TECHNOLOGY SEGMENT IS PROJECTED TO GROW FASTER THAN QPCR TECHNOLOGY SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 37: REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO DOMINATE THE QPCR PRODUCTS & SERVICES MARKET DURING 2017-2022
  • FIGURE 38: INSTRUMENTS ARE EXPECTED TO DOMINATE THE DPCR PRODUCTS & SERVICES MARKET DURING 2017-2022
  • FIGURE 39: CLINICAL APPLICATION TO DOMINATE THE GLOBAL QPCR MARKET DURING 2017-2022
  • FIGURE 40: CLINICAL APPLICATIONS TO DOMINATE THE GLOBAL DPCR MARKET DURING 2017-2022
  • FIGURE 41: HOSPITALS AND DIAGNOSTIC CENTERS TO DOMINATE THE QPCR END USER MARKET DURING 2017-2022
  • FIGURE 42: RESEARCH LABS AND ACADEMIC INSTITUTES TO DOMINATE THE DPCR END-USER MARKET DURING 2017-2022
  • FIGURE 43: NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT
  • FIGURE 44: EUROPE: DPCR AND QPCR MARKET SNAPSHOT
  • FIGURE 45: ASIA-PACIFIC: DPCR AND QPCR MARKET SNAPSHOT
  • FIGURE 46: ROW: DPCR AND QPCR MARKET SNAPSHOT
  • FIGURE 47: DPCR AND QPCR MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING
  • FIGURE 48: GLOBAL QPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2016)
  • FIGURE 49: GLOBAL DPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2016)
  • FIGURE 50: GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS (2016)
  • FIGURE 51: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 52: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 53: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 54: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 55: TAKARA BIO, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 56: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 57: BIOMERIEUX S.A.: COMPANY SNAPSHOT (2016)
  • FIGURE 58: FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 59: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 60: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 61: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 62: BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 63: MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT (2016)
Back to Top